Results 211 to 220 of about 55,685 (249)

Positron emission tomography imaging of T-cell activity in cardiovascular disease and its emerging role in imaging adaptive immunity. [PDF]

Am J Nucl Med Mol Imaging
Uddin AS, Bulusu S, Oderinde OM, Zheng QH.   +3 more
europepmc   +1 more source

Biomarkers in preclinical and early Alzheimer's disease in China: a scoping review. [PDF]

J Prev Alzheimers Dis
Peng G, Yang Y, Wang Y, Chandekar SA, Yu J.   +4 more
europepmc   +1 more source

Porphyrin-lipid nanotheranostics for multimodal imaging of nodal disease in preclinical oral cancers. [PDF]

Theranostics
Valic MS, Najjar E, Zheng M, Townson JL, Chan HHL, Tzelnick S, Ruaro A, El-Sayes A, Halim M, Schimmer P, Zhang CJ, Ye T, Jiang W, Chen J, Irish JC, Zheng G.   +15 more
europepmc   +1 more source

Molecular PET and immuno-PET in gastric cancer immunotherapy: current evidence, clinical utilities, and translational barriers. [PDF]

Front Immunol
Hu Q, Sun Y.
europepmc   +1 more source

Advances in Preclinical PET Instrumentation [PDF]

PET Clinics, 2020
In the light of ever-increasing demands for PET scanner with better resolvability, higher sensitivity and wide accessibility for noninvasive screening of small structures and physiological processes in laboratory rodents, several dedicated PET scanners were developed and evaluated.
Habib Zaidi, Mohammad Reza Ay
exaly   +4 more sources

Preclinical antibody-PET imaging of PD-L1

Frontiers in Nuclear Medicine, 2022
Programmed cell death protein-1/ligand-1 (PD-1/PD-L1) blockade, including antibody therapeutics, has transformed cancer treatment. However, a major challenge in the field relates to selecting patients who are likely to respond to immune checkpoint inhibitors.
Patricia Pereira
exaly   +3 more sources

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook [PDF]

Frontiers in Oncology, 2021
BackgroundProstate specific membrane antigen (PSMA) PET imaging has recently gained attention in glioblastoma (GBM) patients as a potential theranostic target for PSMA radioligand therapy. However, PSMA PET has not yet been established in a murine GBM model.
Claus Belka, Lena Kaiser, Johannes Notni   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Applications for Preclinical PET/MRI

Seminars in Nuclear Medicine, 2013
Currently, the combination of positron emission tomography (PET) and magnetic resonance imaging (MRI) as a hybrid imaging modality is receiving great attention not only in its emerging clinical applications but also in the preclinical field. Several prototypes based on several different types of PET detector technology have been developed in recent ...
Martin S, Judenhofer, Simon R, Cherry
openaire   +2 more sources

SimPET: a Preclinical PET Insert for Simultaneous PET/MR Imaging

Molecular Imaging and Biology, 2020
SimPET/M7 system is a small-animal dedicated simultaneous positron emission tomography and magnetic resonance imaging (PET/MRI) scanner. The SimPET insert has been upgraded from its prototype with a focus on count rate performance and sensitivity. The M7 scanner is a 1-T permanent magnet-based compact MRI system without any cryogens.
Jeong-Whan, Son, Kyeong Yun, Kim, Ji Yong, Park, Kyuwan, Kim, Yun-Sang, Lee, Guen Bae, Ko, Jae Sung, Lee   +6 more
openaire   +2 more sources

Preclinical Studies with Small Animal PET

PET Clinics, 2011
Because no effective cures are available for cutaneous malignant melanoma, early diagnosis and accurate staging are of the utmost importance in increasing patient survival. Fluorodeoxyglucose positron emission tomography (PET)/computed tomography is a functional imaging technique that has contributed to ameliorating surveillance of patients with ...
NANNI, CRISTINA, FANTI, STEFANO
openaire   +3 more sources